OrthoPediatrics Corp (KIDS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:OrthoPediatrics Corp (KIDS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11415
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OrthoPediatrics Corp (OrthoPediatrics) is a medical device company that designs, develops and distributes implants and instruments. The company offers trauma and deformity, spine, sports medicine, and clinical education products. It provides cannulated screws, spine system, ACL reconstruction system, femur locked plate system, tibia locked plate system, extension osteotomy plates, locking cannulated blade, locking proximal femur, MPFL reconstruction system and spica tables. OrthoPediatrics’s ACL reconstruction system consists of iliotibial band reconstruction and versatile drilling instrumentation. The company also provide orthopedic implants for children. It serves to patients and children with orthopaedic conditions and injuries. OrthoPediatrics is headquartered in Warsaw, Indiana, the US.

OrthoPediatrics Corp (KIDS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OrthoPediatrics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
OrthoPediatrics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
OrthoPediatrics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
OrthoPediatrics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
OrthoPediatrics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
OrthoPediatrics Corp, Medical Equipment, Deal Details 10
Partnerships 10
OrthoPediatrics Enters into Distribution Agreement with SpineGuard 10
Equity Offering 11
OrthoPediatrics Plans to Raise up to USD100 Million in Public Offering of Securities 11
OrthoPediatrics Raises USD59.8 Million in IPO 12
OrthoPediatrics Completes Private Placement of Shares for USD37 Million 14
OrthoPediatrics Corp – Key Competitors 15
OrthoPediatrics Corp – Key Employees 16
OrthoPediatrics Corp – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Strategy And Business Planning 18
Aug 14, 2018: OrthoPediatrics announces expansion of its Warsaw headquarters 18
Financial Announcements 19
Oct 31, 2018: OrthoPediatrics reports third quarter 2018 financial results 19
Aug 08, 2018: OrthoPediatrics reports second quarter 2018 financial results 21
May 14, 2018: OrthoPediatrics Announces First Quarter 2018 Financial Results 23
Mar 07, 2018: OrthoPediatrics Reports Fourth Quarter and Full Year 2017 Financial Results 25
Jan 05, 2018: OrthoPediatrics Announces Preliminary Revenue for Fourth Quarter and Full Year 2017 27
Nov 08, 2017: OrthoPediatrics Reports Third Quarter 2017 Financial Results 28
Corporate Communications 30
Dec 15, 2017: OrthoPediatrics Appoints Samuel D. Riccitelli to its Board of Directors 30
Government and Public Interest 31
Apr 09, 2018: OrthoPediatrics Announces Sponsorship of 2018 EPOS Meeting and Lunch Symposium 31
Product News 32
Aug 10, 2018: OrthoPediatrics to Present at FDA Conference on Pediatric Devices 32
Nov 27, 2017: OrthoPediatrics to Highlight its Products at the 14th Annual International Pediatric Orthopaedic Symposium 33
Other Significant Developments 34
May 10, 2018: OrthoPediatrics Supports Third Medical Mission with World Pediatric Project 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
OrthoPediatrics Corp, Medical Equipment, Key Facts, 2017 2
OrthoPediatrics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
OrthoPediatrics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
OrthoPediatrics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
OrthoPediatrics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
OrthoPediatrics Corp, Deals By Market, 2012 to YTD 2018 8
OrthoPediatrics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
OrthoPediatrics Enters into Distribution Agreement with SpineGuard 10
OrthoPediatrics Plans to Raise up to USD100 Million in Public Offering of Securities 11
OrthoPediatrics Raises USD59.8 Million in IPO 12
OrthoPediatrics Completes Private Placement of Shares for USD37 Million 14
OrthoPediatrics Corp, Key Competitors 15
OrthoPediatrics Corp, Key Employees 16

List of Figures
OrthoPediatrics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
OrthoPediatrics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
OrthoPediatrics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
OrthoPediatrics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
OrthoPediatrics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
OrthoPediatrics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
OrthoPediatrics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
OrthoPediatrics Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[OrthoPediatrics Corp (KIDS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Boehringer Ingelheim GmbH:企業の戦略的SWOT分析
    Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Symrise AG (SY1):製薬・医療:M&Aディール及び事業提携情報
    Summary Symrise AG (Symrise) offers flavors and fragrances. The company develops, produces and sells flavorings, fragrances, cosmetic active ingredients and raw materials, and functional ingredients and solutions for the cosmetics industry. It also provides biofunctional and bioactive ingredients an …
  • Presidio Inc (PSDO):企業の財務・戦略的SWOT分析
    Presidio Inc (PSDO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • China CAMC Engineering Co Ltd (002051):企業の財務・戦略的SWOT分析
    Summary China CAMC Engineering Co Ltd (CAMC), a subsidiary of China National Machinery Industry Corp, is a construction company that offers engineering, procurement and construction services. The company designs and constructs shipyard, turnkey project in pulp plant, agricultural equipment industria …
  • CIMB Group Holdings Berhad:戦略・SWOT・企業財務分析
    CIMB Group Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary CIMB Group Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Tenaska Inc:発電所・企業SWOT分析
    Tenaska Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Nikkei Inc.:企業の戦略的SWOT分析
    Nikkei Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Exor N.V:企業の戦略・SWOT・財務分析
    Exor N.V - Strategy, SWOT and Corporate Finance Report Summary Exor N.V - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Falck Renewables S.p.A. (FKR):企業の財務・戦略的SWOT分析
    Falck Renewables S.p.A. (FKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Illinois Municipal Electric Agency:企業の戦略的SWOT分析
    Illinois Municipal Electric Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Beijer Ref Ab:企業のM&A・事業提携・投資動向
    Beijer Ref Ab - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Beijer Ref Ab Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Total Energy Services Inc (TOT):石油・ガス:M&Aディール及び事業提携情報
    Summary Total Energy Services Inc (Total Energy) is an energy services company. It offers contract drilling services and rental and transportation services for equipment utilized in drilling, completion and production activities in oil and gas wells. The company also provides fabrication, sale, rent …
  • European Medical Contract Manufacturing BV:医療機器:M&Aディール及び事業提携情報
    Summary European Medical Contract Manufacturing BV (EMCM BV), a subsidiary of Leader Biomedical Group, is a developer and manufacturer of sterile medicinal products. The company’s products include bone cements for hip and knee arthroplasty and vertebroplasty procedures; cement restrictors; human bon …
  • Asarina Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB, is a sepranolone product developer. The company offers discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cyc …
  • First Republic Bank:企業のM&A・事業提携・投資動向
    First Republic Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Republic Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Scottish and Southern Energy plc:企業の戦略・SWOT・財務分析
    Scottish and Southern Energy plc - Strategy, SWOT and Corporate Finance Report Summary Scottish and Southern Energy plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Al Hassan Engineering Co (HECI):企業の財務・戦略的SWOT分析
    Al Hassan Engineering Co (HECI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Bassett Furniture Industries Inc (BSET):企業の財務・戦略的SWOT分析
    Bassett Furniture Industries Inc (BSET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Schmack Biogas GmbH:企業の戦略的SWOT分析
    Schmack Biogas GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Pharma Mar SA (PHM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Mar SA (Pharma Mar) is a biopharmaceutical company that discovers, develops and markets marine-derived drugs to treat cancer. The company’s marketed product Yondelis (trabectedin), a novel, multimodal, synthetically produced antitumor agent, is indicated for the treatment of advanced …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆